JPS63109799A - Dry cholesterol-analyzing element - Google Patents
Dry cholesterol-analyzing elementInfo
- Publication number
- JPS63109799A JPS63109799A JP11763687A JP11763687A JPS63109799A JP S63109799 A JPS63109799 A JP S63109799A JP 11763687 A JP11763687 A JP 11763687A JP 11763687 A JP11763687 A JP 11763687A JP S63109799 A JPS63109799 A JP S63109799A
- Authority
- JP
- Japan
- Prior art keywords
- layer
- cholesterol
- water
- liquid
- reagent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007788 liquid Substances 0.000 claims abstract description 32
- 102000004190 Enzymes Human genes 0.000 claims abstract description 13
- 108090000790 Enzymes Proteins 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- 238000003892 spreading Methods 0.000 claims description 23
- 229920002557 polyglycidol polymer Polymers 0.000 claims description 9
- 150000001840 cholesterol esters Chemical class 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 6
- 238000010931 ester hydrolysis Methods 0.000 claims description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 42
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 30
- 235000012000 cholesterol Nutrition 0.000 abstract description 22
- 238000004737 colorimetric analysis Methods 0.000 abstract description 5
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 150000001841 cholesterols Chemical class 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 122
- 108010010803 Gelatin Proteins 0.000 description 16
- 229920000159 gelatin Polymers 0.000 description 16
- 239000008273 gelatin Substances 0.000 description 16
- 235000019322 gelatine Nutrition 0.000 description 16
- 235000011852 gelatine desserts Nutrition 0.000 description 16
- 238000010521 absorption reaction Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- -1 alkylphenyl ether Chemical compound 0.000 description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 239000012790 adhesive layer Substances 0.000 description 12
- 239000004744 fabric Substances 0.000 description 12
- 239000000975 dye Substances 0.000 description 11
- 238000004040 coloring Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 8
- 108010055297 Sterol Esterase Proteins 0.000 description 8
- 102000000019 Sterol Esterase Human genes 0.000 description 8
- 229960003964 deoxycholic acid Drugs 0.000 description 8
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 8
- 238000011161 development Methods 0.000 description 8
- 229920001477 hydrophilic polymer Polymers 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical group OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 7
- 239000010419 fine particle Substances 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000004367 Lipase Substances 0.000 description 5
- 108090001060 Lipase Proteins 0.000 description 5
- 102000004882 Lipase Human genes 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 108010023417 cholesterol dehydrogenase Proteins 0.000 description 5
- 235000019421 lipase Nutrition 0.000 description 5
- 108010085346 steroid delta-isomerase Proteins 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 239000002253 acid Substances 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 239000005020 polyethylene terephthalate Substances 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 3
- 241000588881 Chromobacterium Species 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 239000007900 aqueous suspension Substances 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000011088 calibration curve Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- GGCLNOIGPMGLDB-GYKMGIIDSA-N cholest-5-en-3-one Chemical compound C1C=C2CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 GGCLNOIGPMGLDB-GYKMGIIDSA-N 0.000 description 3
- NYOXRYYXRWJDKP-UHFFFAOYSA-N cholestenone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 NYOXRYYXRWJDKP-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000012992 electron transfer agent Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- 125000006353 oxyethylene group Chemical group 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000004445 quantitative analysis Methods 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 239000002759 woven fabric Substances 0.000 description 3
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- JWAZRIHNYRIHIV-UHFFFAOYSA-N 2-naphthol Chemical compound C1=CC=CC2=CC(O)=CC=C21 JWAZRIHNYRIHIV-UHFFFAOYSA-N 0.000 description 2
- 108010089254 Cholesterol oxidase Proteins 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical group OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000006356 dehydrogenation reaction Methods 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229910003002 lithium salt Inorganic materials 0.000 description 2
- 159000000002 lithium salts Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000123 paper Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical class [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
- PWJNDVAKQLOWRZ-UHFFFAOYSA-N 1-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=CC=C2C(O)=C(S(O)(=O)=O)C=CC2=C1 PWJNDVAKQLOWRZ-UHFFFAOYSA-N 0.000 description 1
- IOAOAKDONABGPZ-UHFFFAOYSA-N 2-amino-2-ethylpropane-1,3-diol Chemical compound CCC(N)(CO)CO IOAOAKDONABGPZ-UHFFFAOYSA-N 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- MMAFPMQOIUHLNH-UHFFFAOYSA-N 2-hydroxy-3-methoxybenzenesulfonic acid Chemical compound COC1=CC=CC(S(O)(=O)=O)=C1O MMAFPMQOIUHLNH-UHFFFAOYSA-N 0.000 description 1
- IULJSGIJJZZUMF-UHFFFAOYSA-N 2-hydroxybenzenesulfonic acid Chemical compound OC1=CC=CC=C1S(O)(=O)=O IULJSGIJJZZUMF-UHFFFAOYSA-N 0.000 description 1
- LWKJNIMGNUTZOO-UHFFFAOYSA-N 3,5-dichloro-2-hydroxybenzenesulfonic acid Chemical compound OC1=C(Cl)C=C(Cl)C=C1S(O)(=O)=O LWKJNIMGNUTZOO-UHFFFAOYSA-N 0.000 description 1
- TWIQNOGDMNOEGC-UHFFFAOYSA-N 4-amino-1,2-dimethylpyrazol-3-one Chemical compound CN1C=C(N)C(=O)N1C TWIQNOGDMNOEGC-UHFFFAOYSA-N 0.000 description 1
- UPXGPQPWPYGPBF-UHFFFAOYSA-N 4-amino-2-(3,5-dichlorophenyl)-1,5-dimethylpyrazol-3-one Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC(Cl)=CC(Cl)=C1 UPXGPQPWPYGPBF-UHFFFAOYSA-N 0.000 description 1
- FEPBITJSIHRMRT-UHFFFAOYSA-N 4-hydroxybenzenesulfonic acid Chemical compound OC1=CC=C(S(O)(=O)=O)C=C1 FEPBITJSIHRMRT-UHFFFAOYSA-N 0.000 description 1
- HGWQOFDAUWCQDA-UHFFFAOYSA-N 4-hydroxynaphthalene-1-sulfonic acid Chemical compound C1=CC=C2C(O)=CC=C(S(O)(=O)=O)C2=C1 HGWQOFDAUWCQDA-UHFFFAOYSA-N 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- 241001147825 Actinomyces sp. Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241000146387 Chromobacterium viscosum Species 0.000 description 1
- 108010035713 Glycodeoxycholic Acid Proteins 0.000 description 1
- WVULKSPCQVQLCU-UHFFFAOYSA-N Glycodeoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCC(O)=O)C)C1(C)C(O)C2 WVULKSPCQVQLCU-UHFFFAOYSA-N 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SMEROWZSTRWXGI-UHFFFAOYSA-N Lithocholsaeure Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 SMEROWZSTRWXGI-UHFFFAOYSA-N 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 241000228168 Penicillium sp. Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 241000187180 Streptomyces sp. Species 0.000 description 1
- WBWWGRHZICKQGZ-UHFFFAOYSA-N Taurocholic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(=O)NCCS(O)(=O)=O)C)C1(C)C(O)C2 WBWWGRHZICKQGZ-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 210000001557 animal structure Anatomy 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229950011260 betanaphthol Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- RUDATBOHQWOJDD-BSWAIDMHSA-N chenodeoxycholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-BSWAIDMHSA-N 0.000 description 1
- 229960001091 chenodeoxycholic acid Drugs 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- WVULKSPCQVQLCU-BUXLTGKBSA-N glycodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 WVULKSPCQVQLCU-BUXLTGKBSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- SMEROWZSTRWXGI-HVATVPOCSA-N lithocholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 SMEROWZSTRWXGI-HVATVPOCSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- NXPPAOGUKPJVDI-UHFFFAOYSA-N naphthalene-1,2-diol Chemical compound C1=CC=CC2=C(O)C(O)=CC=C21 NXPPAOGUKPJVDI-UHFFFAOYSA-N 0.000 description 1
- 150000002790 naphthalenes Chemical class 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- QWUFXJHVFNRNCU-UHFFFAOYSA-N phenazin-1-amine Chemical compound C1=CC=C2N=C3C(N)=CC=CC3=NC2=C1 QWUFXJHVFNRNCU-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000005375 photometry Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000001008 quinone-imine dye Substances 0.000 description 1
- 239000012070 reactive reagent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- WBWWGRHZICKQGZ-GIHLXUJPSA-N taurocholic acid Chemical compound C([C@@H]1C[C@H]2O)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@H](O)C1 WBWWGRHZICKQGZ-GIHLXUJPSA-N 0.000 description 1
- AWDRATDZQPNJFN-VAYUFCLWSA-N taurodeoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS(O)(=O)=O)C)[C@@]2(C)[C@@H](O)C1 AWDRATDZQPNJFN-VAYUFCLWSA-N 0.000 description 1
- FBWNMEQMRUMQSO-UHFFFAOYSA-N tergitol NP-9 Chemical compound CCCCCCCCCC1=CC=C(OCCOCCOCCOCCOCCOCCOCCOCCOCCO)C=C1 FBWNMEQMRUMQSO-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Abstract
Description
【発明の詳細な説明】
し産業上の利用分野コ
本発明は血液等の体液中のコレステロール、特に蛋白結
合コレステロールを含む総コレステロールの分析に適す
る乾式分析要素に関する。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a dry analytical element suitable for analyzing cholesterol in body fluids such as blood, particularly total cholesterol including protein-bound cholesterol.
[従来の技術]
コレステロールエステルを加水分解するために、コレス
テロールエステラーゼ等の酵素を利用する方法はよく知
られている。しかしこの方法の場合に、酵素以外に蛋白
質−コレスチロールエステルの結合を破壊しコレステロ
ールエステルを解離させる手段を必要とすることもよく
知られている。[Prior Art] Methods using enzymes such as cholesterol esterase to hydrolyze cholesterol esters are well known. However, it is well known that this method requires a means other than enzymes to break the protein-cholestyrol ester bond and dissociate the cholesterol ester.
米国特許3869349号で、リパーゼとともにプロテ
アーゼを用いることが知られている。また米国特許39
25164号では、コレステロールエステラーゼととも
にポリエチレングリコールアルキルエーテルのような界
面活性剤を用いることが知られている。また、米国特許
4275151号、同4274152号には、エチレン
グリコール単位が20未満のポリエチレングリコールア
ルキルフェニルエーテル(アルキルフェノキシポリエト
キシエタノール)が有用なことが記載されている。It is known from US Pat. No. 3,869,349 to use proteases together with lipases. Also, U.S. Patent No. 39
No. 25164, it is known to use a surfactant such as polyethylene glycol alkyl ether together with cholesterol esterase. Further, US Pat. No. 4,275,151 and US Pat. No. 4,274,152 describe that polyethylene glycol alkylphenyl ether (alkylphenoxypolyethoxyethanol) having less than 20 ethylene glycol units is useful.
しかし多孔性液体展開層(以下、多孔性展1fFI肩又
は展開層という)を有する乾式分析要素に、エチレング
リコール単位が20未満のポリエチレングリコールアル
キルフェニルエーテルを酵素とともに展開層に含有させ
たとき、この界面活性剤は一定時間内の液体展開面積が
大き過ぎて、比色分析の感度が低下したり、液体展開の
定員性(供給液量と展開面積の比例性)が充分でなかっ
たり、塗布液の展開層に対する濡れ特性が不充分であっ
たりする欠点があった。また、展開層と支持体との間に
ある吸水層、試薬層、光遮蔽層、接着層等の親水性バイ
ンダーからなる層にこの界面活性剤を含有させたとき、
ある層と次に塗布される層の塗布液の濡れが不充分で、
塗布が不均一になることがしばしばあった。However, when a polyethylene glycol alkyl phenyl ether containing less than 20 ethylene glycol units is contained in a dry analytical element having a porous liquid spreading layer (hereinafter referred to as a porous liquid spreading layer or spreading layer) together with an enzyme, this Surfactants may cause the liquid development area within a certain period of time to be too large, reducing the sensitivity of colorimetric analysis, or the capacity of liquid development (proportionality between the amount of supplied liquid and the development area) being insufficient, or the coating liquid The problem was that the wetting properties for the spreading layer were insufficient. Furthermore, when this surfactant is contained in a layer consisting of a hydrophilic binder such as a water absorption layer, a reagent layer, a light shielding layer, or an adhesive layer between the spreading layer and the support,
Insufficient wetting of the coating solution between one layer and the next layer,
Application was often uneven.
[発明が解決しようとする問題点]
本発明の目的は、一定時間内の液体展開面積が適当で、
蛋白結合コレステロールを含めた総コレステロールに対
する比色分析の感度が高い乾式コレステロール分析要素
の提供にある。[Problems to be Solved by the Invention] The purpose of the present invention is to ensure that the liquid development area within a certain period of time is appropriate;
An object of the present invention is to provide a dry cholesterol analysis element that has high sensitivity in colorimetric analysis of total cholesterol including protein-bound cholesterol.
本発明の他の目的は、展開層における液体展開の定量性
(供給液量と展開面積の比例性)が充分で、塗布液の均
一な塗布が可能な乾式コレステロール分析要素の提供に
ある。Another object of the present invention is to provide a dry cholesterol analysis element that has sufficient quantitative property (proportionality between the amount of supplied liquid and the area of development) of the liquid in the developing layer and allows uniform coating of the coating liquid.
[発明の構成]
本発明の上記目的は、少なくとも一つの水透過性層と多
孔性液体展開層を液体接触しうる状態で有する乾式分析
要素であって、前記展開層にコレステロールエステル加
水分解活性(コレステロールエステルヒドロラーゼ活性
)を有する酵素を含み、前記展rWi層又は前記の少な
くとも一つの水透過性層にアルキルフェノキシポリグリ
シドールを含む乾式分析要素によって達成された。[Structure of the Invention] The above-mentioned object of the present invention is to provide a dry analytical element having at least one water-permeable layer and a porous liquid spreading layer in a state where they can come into liquid contact with each other, the developing layer having cholesterol ester hydrolysis activity ( This was achieved by means of a dry analytical element containing an enzyme with cholesterol ester hydrolase activity) and containing an alkylphenoxy polyglycidol in said rWi layer or said at least one water-permeable layer.
[発明の構成の詳細な説明]
本発明に用いるコレステロールエステル加水分解活性を
有する酵素は、リパーゼまたはコレステロールエステラ
ーゼのいずれでもよい、リパーゼは、植物(例えば小麦
胚)を起源とするもの、動物臓器(例えば膵臓)を起源
とするもの、微生物(例えばカンジダルゴサ)を起源と
するものいずれでもよい、特にChromobacte
rium viseosusから得られたものが有用で
ある。[Detailed Description of the Structure of the Invention] The enzyme having cholesterol ester hydrolysis activity used in the present invention may be either lipase or cholesterol esterase. For example, Chromobacterium may originate from the pancreas) or from microorganisms (e.g. Candidalgosa), especially Chromobacterium.
Those obtained from Rium viseosus are useful.
コレステロールエステラーゼは動物臓器を起源とするも
の、微生物を起源とするもの、いずれでもよいが、微生
物を起源とするものが好ましい1例えば、米国特許39
25164号に記載されたものを用いることができる(
カンジダルゴサ、アクチノミセス属、ストレプトミセス
属、ペニシリウム属等)。Cholesterol esterase may be derived from animal organs or microorganisms, but those originating from microorganisms are preferred 1 For example, U.S. Pat.
What is described in No. 25164 can be used (
Candidalgosa, Actinomyces sp., Streptomyces sp., Penicillium sp., etc.).
本発明に用いるアルキルフェノキシポリグリシドールは
、アルキル基が炭素数4ないし20のものが好ましい、
アルキル基はベンゼン環に2以上置換していてもよい(
ジアルキルフェノキシポリグリシドール等)、ベンゼン
環はアルキル基以外の置換基、例えばアルコキシ基、ハ
ロゲン原子などを有してもよい0分子中のグリシドール
単位は7ないし20の範囲が適当であるが、塗布特性、
展開特性等、目的によってグリシドール単位の数は選択
される。The alkylphenoxy polyglycidol used in the present invention preferably has an alkyl group having 4 to 20 carbon atoms.
Two or more alkyl groups may be substituted on the benzene ring (
(dialkyl phenoxy polyglycidol, etc.), the benzene ring may have a substituent other than an alkyl group, such as an alkoxy group, a halogen atom, etc. The number of glycidol units per molecule is preferably in the range of 7 to 20, but the coating properties ,
The number of glycidol units is selected depending on the purpose such as expansion characteristics.
アルキルフェノキシポリグリシドールはコレステロール
エステル加水分解活性を有する酵素とともに多孔性展開
層に含有させることが好ましい。It is preferable that the alkyl phenoxy polyglycidol is contained in the porous developing layer together with an enzyme having cholesterol ester hydrolyzing activity.
コレステロールを検出定量するためには、公知の反応の
検出試薬組成物を利用できる。公知の検出反応として次
の2種類がある。In order to detect and quantify cholesterol, a detection reagent composition for a known reaction can be used. There are two types of known detection reactions:
■コレステロールをコレスプロールオキシダーゼの酵素
活性によって酸化し、生成した過酸化水素またはコレス
テノンを公知の発色(呈色)反応又はコレステノンの蛍
光により検出定量する。(2) Cholesterol is oxidized by the enzymatic activity of cholesprol oxidase, and the generated hydrogen peroxide or cholestenone is detected and quantified by a known coloring reaction or by the fluorescence of cholestenone.
■コレステロールデヒドロゲナーゼの酵素活性による脱
水素反応で、生成したコレステノンを公知の反応により
検出定量するか、脱水素反応に共役してNAD又はNA
DPの還元により生ずるNADH又はN A D P
tlを、直接光学的に検出定量するか、又はさらに化学
反応を介して生成する有色物質を光学的に検出定量する
。■Cholestenone produced by the dehydrogenation reaction by the enzyme activity of cholesterol dehydrogenase can be detected and quantified by a known reaction, or it can be conjugated to the dehydrogenation reaction to form NAD or NA.
NADH or N A D P produced by reduction of DP
tl is directly detected and quantified optically, or a colored substance produced through a chemical reaction is further detected and quantified optically.
■コレステロールオキシダーゼにより生成した過酸化水
素を検出する発色試薬組成物は[^]色原体とカプラー
を含み、ペルオキシダーゼの存在下に過酸化水素により
色原体とカプラーが酸化カプリングしてキノンイミン染
料を形成して発色する組成物、または
[1’!]ロイコ色素又は自己酸化発色性色原体でペル
オキシダーゼの存在下に過酸化水素により酸化されて色
素になり発色する化合物である。■The coloring reagent composition for detecting hydrogen peroxide produced by cholesterol oxidase [^] contains a chromogen and a coupler, and the chromogen and coupler are oxidatively coupled by hydrogen peroxide in the presence of peroxidase to form a quinone imine dye. A composition that forms and develops color, or [1'! ] Leuco pigments or autooxidative color-forming chromogens are compounds that are oxidized by hydrogen peroxide in the presence of peroxidase to become pigments and develop color.
色原体としては、^11. (:lil、 Biocb
em、、124〜27(1969)に記載の4−アミノ
アンチとリン(別名4−アミノフェナジン、すなわち1
−フェニル−2,3−ジメチル−4−アミノ−3−ピラ
ゾリン−5−オン)、特開昭59−54962等に記載
の1−(2,4,6−)リクロロフェニル)−2,3−
ジメチル−4−アミノ−3−ピラゾリン−5−オン。As a chromogen, ^11. (:lil, Biocb
4-aminoanti and phosphorus (also known as 4-aminophenazine, i.e. 1
-phenyl-2,3-dimethyl-4-amino-3-pyrazolin-5-one), 1-(2,4,6-)lichlorophenyl)-2,3- described in JP-A-59-54962, etc.
Dimethyl-4-amino-3-pyrazolin-5-one.
1−(3,5−ジクロロフェニル)−2,3−ジメチル
−4−アミノ−3−ピラゾリン−5−オン等のトリi!
ftA−4−アミノー3−ピラゾリン−5−オン、特公
昭55−25840等に記載の1−フェニル−2,3−
ジメチル−4−ジメチルアミノ−3−ピラゾリン−5−
オン等の4−アミノアンチピリン類似体を用いることが
できる。これらの化合物のうちでは、4−アミノアンチ
ピリン、1−(2,4,6−)ジクロロフェニル)−2
,3−ジメチル−4−アミノ−3−ピラゾリン−5−オ
ン、1−(3,5−ジクロロフェニル)−2,3−ジメ
チル−4−アミノ−3−ピラゾリン−5−オン等が好ま
しい。Trii! such as 1-(3,5-dichlorophenyl)-2,3-dimethyl-4-amino-3-pyrazolin-5-one!
ftA-4-amino-3-pyrazolin-5-one, 1-phenyl-2,3- as described in Japanese Patent Publication No. 55-25840, etc.
Dimethyl-4-dimethylamino-3-pyrazoline-5-
4-aminoantipyrine analogs such as ion can be used. Among these compounds, 4-aminoantipyrine, 1-(2,4,6-)dichlorophenyl)-2
, 3-dimethyl-4-amino-3-pyrazolin-5-one, 1-(3,5-dichlorophenyl)-2,3-dimethyl-4-amino-3-pyrazolin-5-one, and the like are preferred.
カプラーとしては、^nn、 Cl1n、 Bioch
em、、6.24〜2バ1969)、特公昭55−25
840、特公昭58−45599、特公昭58−186
28、特開昭55−164356、特開昭56=124
398、特開昭56−155852等に記載のフェノー
ル、2−ヒドロキシ−1−ベンゼンスルホン酸、4−ヒ
ドロキシ−1−ベンゼンスルホン酸、3.5−ジクロロ
−2−ヒドロキシ−1−ベンゼンスルホン酸、2−ヒド
ロキシ−3−メトキシ−1−ベンゼンスルホン酸等のフ
ェノールスルホン酸(アルカリ金属塩、アルカリ土類金
属塩を含む);1−ナフトール、2−ナフトール;1,
7−ジヒドロキシナフタレン等のジヒドロキシナフタレ
ン;1−ヒドロキシ−2−ナフタレンスルホン酸、1−
ヒドロキシ−4−ナフタレンスルホン酸等のナフトール
スルホン酸くアルカリ金属塩、アルカリ土類金属塩を含
む);その他のフェノール又はナフ1−−ル誘導体があ
る。これらの化合物のうちでは、1゜7−ジヒドロキシ
ナフタレン、i−ヒドロキシ−2−ナフタレンスルホン
酸(Na塩、に塩、Li塩を含む)、3.5−ジクロロ
−2−ヒドロキシ−1−ベンゼンスルホン?!!(Na
塩、に塩、L;塩を含む)が好ましい。Couplers include ^nn, Cl1n, Bioch
em, 6.24-2ba 1969), Special Publication 1984-25
840, Special Publication No. 58-45599, Special Publication No. 58-186
28, JP-A-55-164356, JP-A-56=124
Phenol, 2-hydroxy-1-benzenesulfonic acid, 4-hydroxy-1-benzenesulfonic acid, 3,5-dichloro-2-hydroxy-1-benzenesulfonic acid, as described in No. 398, JP-A-56-155852, etc. Phenolsulfonic acids such as 2-hydroxy-3-methoxy-1-benzenesulfonic acid (including alkali metal salts and alkaline earth metal salts); 1-naphthol, 2-naphthol; 1,
Dihydroxynaphthalene such as 7-dihydroxynaphthalene; 1-hydroxy-2-naphthalenesulfonic acid, 1-
(including alkali metal salts and alkaline earth metal salts of naphtholsulfonic acid such as hydroxy-4-naphthalenesulfonic acid); and other phenol or naphthalene derivatives. Among these compounds, 1゜7-dihydroxynaphthalene, i-hydroxy-2-naphthalenesulfonic acid (including Na salt, Ni salt, and Li salt), 3,5-dichloro-2-hydroxy-1-benzenesulfone ? ! ! (Na
salt, ni salt, L; including salt) is preferred.
ロイコ色素として、特公昭57−5519に記載の2−
(4−ヒドロキシ−3,5−ジメトキシフェニル)−4
,5−ビス[4−(ジメチルアミノ)フェニルコイミダ
ゾール等のトリアリールイミダゾールロイコ色素、特開
昭59−193352に記載の2−(3,5−ジメトキ
シ−4−ヒドロキシフェニル)−4−[4−(ジメチル
アミノ)フェニル]−5−フェネチルイミダゾール等の
ジアリールイミダゾールロイコ色素、特開昭61−49
60に記載の2−(2−フェニル−3−インドリル)−
4,5−ジ[4−(ジメチルアミノ)フェニルコイミダ
ゾール等のジアリールインドリルイミダゾールロイコ色
素、特開昭61−229868に記載の2−(4−ヒド
ロキシ−3,5−ジメトキシフェニル)−3−アセチル
−4,5−ビス[4−(ジエチルアミノ)フェニルコイ
ミダゾール等のトリアリールモノアシルイミダゾールロ
イコ色素、2−(4−ヒドロキシ−3,5−ジメトキシ
フェニル)−3−メチル−4,5−ビ、t [4−(ジ
エチルアミノ)フェニルコイミダゾール等のトリアリー
ルモノアルキルイミダゾールロイコ色素等がある。As a leuco dye, 2-
(4-hydroxy-3,5-dimethoxyphenyl)-4
, 5-bis[4-(dimethylamino)phenylcoimidazole and other triarylimidazole leuco dyes, 2-(3,5-dimethoxy-4-hydroxyphenyl)-4-[4 described in JP-A-59-193352 Diarylimidazole leuco dyes such as -(dimethylamino)phenyl]-5-phenethylimidazole, JP-A-61-49
2-(2-phenyl-3-indolyl)- as described in 60
Diarylindolylimidazole leuco dyes such as 4,5-di[4-(dimethylamino)phenylcoimidazole, 2-(4-hydroxy-3,5-dimethoxyphenyl)-3- described in JP-A-61-229868; triarylmonoacylimidazole leuco dyes such as acetyl-4,5-bis[4-(diethylamino)phenylcoimidazole, 2-(4-hydroxy-3,5-dimethoxyphenyl)-3-methyl-4,5-bis , t[4-(diethylamino)phenylcoimidazole and other triarylmonoalkylimidazole leuco dyes.
■N A D 1−1またはNADPHを定量する方法
として、電子伝達剤の存在下に電子受容性の色素前駆体
から可視域に吸収スペクトルを有するフォルマザン色素
を形成させる比色分析法が、特開昭49−11395号
等で知られている。この反応系を用いれば、可視域の分
光測光によりN A D HまたはNADPHの定量が
できる。■As a method for quantifying NAD 1-1 or NADPH, a colorimetric analysis method in which a formazan dye having an absorption spectrum in the visible region is formed from an electron-accepting dye precursor in the presence of an electron transfer agent has been disclosed in Japanese Patent Publication No. It is known from No. 11395, 1973, etc. Using this reaction system, NAD H or NADPH can be quantified by spectrophotometry in the visible range.
電子伝達剤としては、ジアホラーゼ(EC1,6,4゜
3〉、N−メチルフェナゾニウムメトスルフェート等を
用いることができる。As the electron transfer agent, diaphorase (EC1,6,4°3), N-methylphenazonium methosulfate, etc. can be used.
フォルマザン色素前駆体としては、INTすなわち2−
(p−ヨードフ、エニル)−3−(p−ニトロフェニル
)−5〜フエニルテトラゾリウムクロリド、BT すな
わち3.3’−(3,3°−ジメトキシ−4,4′−ビ
フェニレン)ビス[2,5−ジフェニルテトラゾリウム
クロリド]、3.3’−(4,4’−ビフェニレン)ビ
ス[2,5−ジフェニルテトラゾリウムクロリド]等を
用いることもできるが、ニトロテトラゾリウムブルー(
NTB又はNl3T)すなわち3,3°−(3,3’−
ジメトキシ−4,4’ −ビフェニレン〉ビス[2−(
p−、ニトロフェニル)−5−フェニルテトラゾリウム
クロリド]が好ましい。As a formazan dye precursor, INT or 2-
(p-iodoph,enyl)-3-(p-nitrophenyl)-5-phenyltetrazolium chloride, BT i.e. 3,3'-(3,3°-dimethoxy-4,4'-biphenylene)bis[2, Although nitrotetrazolium blue (
NTB or Nl3T) or 3,3°-(3,3'-
dimethoxy-4,4'-biphenylene〉bis[2-(
p-, nitrophenyl)-5-phenyltetrazolium chloride] is preferred.
本発明においてはデオキシコール酸又はデオキシコール
酸の塩をコレステロールエステルヒドロラーゼ活性を有
する酵素が含有される層又はその層と液体接触しうる層
(l[i!i接層等)に含有させることができる。デオ
キシコール酸の塩としてはナトリウム塩、カリウム塩、
リチウム塩等を用いることができる。デオキシコール酸
のかわりにコール酸、リトコール酸、ケノデオキシコー
ル酸、タウロコール酸、グリコール酸、タウロデオキシ
コール酸、グリコデオキシコール酸及びこれらのナトリ
ウム塩、カリウム塩、リチウム塩等のいずれか1種又は
2種以−Eの組合わせを用いることができる。In the present invention, deoxycholic acid or a salt of deoxycholic acid may be contained in a layer containing an enzyme having cholesterol ester hydrolase activity or in a layer that can be in liquid contact with the layer (l[i!i contact layer, etc.). can. Salts of deoxycholic acid include sodium salt, potassium salt,
Lithium salts and the like can be used. Instead of deoxycholic acid, any one or two of cholic acid, lithocholic acid, chenodeoxycholic acid, taurocholic acid, glycolic acid, taurodeoxycholic acid, glycodeoxycholic acid, and their sodium salts, potassium salts, lithium salts, etc. A combination of the following can be used.
本発明の要素に用いられる試薬組成物の各成分の要素中
の含有層(要素1z2当たり被覆It)は次のとおりで
ある。The layers contained in the element (coating It per element 1z2) of each component of the reagent composition used in the element of the present invention are as follows.
コレステロールエステラーゼ:約5ooru〜約5万I
υ、好ましくは約100010〜約3万IUリハ−セ:
約50QOTtl〜約30万TIJ、好ましくは1万I
U〜20万IU
アルキルフェノキシポリグリシドール:約200mg〜
約10g、好ましくは約500611?〜約5.0gコ
レステロールオキシダーゼ:約10001U〜約3万I
IJ、好ましくは約15001U〜約2万IUペルオキ
シダーゼ:約10001U〜約10万、好ましくは約2
000rU〜約6万IU色原体又はロイコ色素:約0.
5ミリモル〜約10ミリリ、好ましくは約1ミリモル〜
約5ミリモルカプラー:約2.5ミリモル〜約50ミリ
モル、好ましくは約5ミリモル〜約25ミリモル
デオキシコール酸又はその塩:約200mH〜約log
、好ましくは約500611?〜約5.0g(デオキシ
コール酸のかわりに用いられる酸又は塩の場合も同jl
)
コレステロールデヒドロゲナーゼ:
約200■U〜約3万■u、好*L<li約300IU
〜約Z万TIJNADまたはNADP:約10++g〜
約50g、好ましくは約30wag〜約20g
電子伝達剤:約IIIg〜約1000mg、好ましくは
約5糟g〜約500aig
ジアホラーゼの場合約5001U〜約2万IU、好まし
くは約7001U〜約1万rU
フオルマザン色素前駆体:約5IIg〜約tog、好ま
しくは約25mg〜約5g
本発明は公知の多種の乾式分析要素に適用することがで
きる。特に検出試薬系と被検液がいずれも透過し得る固
体担体を含む要素に適用することができる。要素は光透
過性水不透過性の支持体上に、多孔性液体展開層のほか
に下塗り層、吸水層、接着層、発色(又は呈色)試薬層
、反応試薬層、光遮蔽層、濾過層、及び公知のその他の
層を有する多層構造であってもよい、このような分析要
素として、米(II特許第3992158号、0開昭5
5−184356号及び特開昭60−222769号等
各明細書に記載のものがある。Cholesterol esterase: about 5000 to about 50,000 I
υ, preferably about 100,010 to about 30,000 IU rehabilitation:
Approximately 50 QOTtl to approximately 300,000 TIJ, preferably 10,000 I
U ~ 200,000 IU Alkylphenoxypolyglycidol: Approximately 200 mg ~
About 10g, preferably about 500611? ~About 5.0g Cholesterol oxidase: Approximately 10,001U ~ Approximately 30,000I
IJ, preferably about 15,001 U to about 20,000 IU Peroxidase: about 10,001 U to about 100,000, preferably about 2
000 rU to about 60,000 IU chromogen or leuco dye: about 0.
5 mmol to about 10 mmol, preferably about 1 mmol to about 1 mmol
About 5 mmol coupler: about 2.5 mmol to about 50 mmol, preferably about 5 mmol to about 25 mmol deoxycholic acid or salt thereof: about 200 mH to about log
, preferably about 500,611? ~ Approximately 5.0 g (same for acids or salts used in place of deoxycholic acid)
) Cholesterol dehydrogenase: Approximately 200 ■U to approximately 30,000 ■U, good*L<li approximately 300IU
~About Z million TIJNAD or NADP: Approximately 10++g~
About 50 g, preferably about 30 wag to about 20 g Electron transfer agent: about IIIg to about 1000 mg, preferably about 5 g to about 500 aig Diaphorase: about 5001 U to about 20,000 IU, preferably about 7001 U to about 10,000 rU Formazan Dye precursor: about 5 IIg to about tog, preferably about 25 mg to about 5 g The present invention can be applied to various known dry analytical elements. In particular, it can be applied to an element containing a solid carrier through which both the detection reagent system and the test liquid can pass. The elements are on a light-transparent and water-impermeable support, in addition to a porous liquid spreading layer, an undercoat layer, a water absorption layer, an adhesive layer, a coloring (or coloring) reagent layer, a reactive reagent layer, a light shielding layer, and a filtration layer. Such an analytical element, which may be a multilayer structure having layers and other layers known in the art, is disclosed in US (II Patent No. 3992158,
There are those described in various specifications such as No. 5-184356 and JP-A No. 60-222769.
支持体を用いる場合、本発明の乾式分析要素の実用的に
採りうる構成は
(+)支持体上に多孔性液体展開層を有するもの。When a support is used, a practical configuration of the dry analytical element of the present invention is (+) having a porous liquid spreading layer on the support.
支持体と展開層の間に吸水層を有するものが好ましい。It is preferable to have a water-absorbing layer between the support and the spreading layer.
(2)支持体上に試薬層、展開層をこの順に有するもの
、支持体と試薬層の間に吸水層を有してもよい。(2) It may have a reagent layer and a developing layer in this order on a support, or it may have a water absorption layer between the support and the reagent layer.
(3)支持体上に第二試薬層、第一試薬層、展開層をこ
の順に有するもの。支持体と第二試薬層の間に吸水層を
有してもよい。(3) A device having a second reagent layer, a first reagent layer, and a developing layer in this order on a support. A water absorption layer may be provided between the support and the second reagent layer.
(4)支持体上に試薬層、光遮蔽層、展開層をこの順に
有するもの、支持体と試薬層の間に吸水層を有してもよ
い。(4) It may have a reagent layer, a light shielding layer, and a developing layer in this order on a support, or it may have a water-absorbing layer between the support and the reagent layer.
(5)支持体上に第二試薬層、光遮蔽層、第一試薬層、
展開層をこの順に有するもの、支持体と第二試薬層の間
に吸水層を有してもよい。(5) a second reagent layer, a light shielding layer, a first reagent layer on the support,
It may have the developing layers in this order, or it may have a water-absorbing layer between the support and the second reagent layer.
上記(1)ないしく5)において吸水層と試薬層又は展
開層の間、試薬層と液体展開層の間、第二試薬層と第一
試薬層の間、又は光遮蔽層と試薬層もしくは展開層の間
に、濾過層を設けてもよい。In (1) to 5) above, between the water absorption layer and the reagent layer or the spreading layer, between the reagent layer and the liquid spreading layer, between the second reagent layer and the first reagent layer, or between the light shielding layer and the reagent layer or the spreading layer. A filtration layer may be provided between the layers.
本発明の多層分析要素には、光透過性水不透過性支持体
の上に(場合によっては下塗層等の他の層を介して)吸
水層を設けることができる0本発明の乾式分析要素に備
えられる吸水層は親水性結合剤よりなる層、すなわち水
を吸収して膨潤する親水性ポリマーを層形成成分とする
層であることが好ましい。The multilayer analytical element of the present invention may include a water-absorbing layer on the light-transparent water-impermeable support (possibly via another layer such as a subbing layer). The water-absorbing layer provided in the element is preferably a layer made of a hydrophilic binder, that is, a layer whose layer-forming component is a hydrophilic polymer that swells upon absorption of water.
吸水層に用いることができる親水性ポリマーは、水吸収
時の膨潤率が30℃で約1,5から約20、好ましくは
約2.5から約15の範囲の天然または合成親水性ポリ
マーである。そのような親水性ポリマーの例としては、
ゼラチン(例、アルカリ処理ゼラチン、酸処理ゼラチン
、脱イオンゼラチン等)、ゼラチン誘導体(例、フタル
化ゼラチン等)、アガロース、ボリアクリルアミド、ポ
リビニルアルコール、ポリビニルピロリドン等をあげる
ことができる。Hydrophilic polymers that can be used in the water-absorbing layer are natural or synthetic hydrophilic polymers having a swelling ratio upon absorption of water ranging from about 1.5 to about 20, preferably from about 2.5 to about 15 at 30°C. . Examples of such hydrophilic polymers include:
Examples include gelatin (eg, alkali-treated gelatin, acid-treated gelatin, deionized gelatin, etc.), gelatin derivatives (eg, phthalated gelatin, etc.), agarose, polyacrylamide, polyvinyl alcohol, polyvinylpyrrolidone, and the like.
吸水層の乾燥時の厚さは約1μlから約100μlの範
囲、好ましくは約3μlから約30μ履の範囲である。The dry thickness of the water absorption layer ranges from about 1 μl to about 100 μl, preferably from about 3 μl to about 30 μl.
さらに吸水層には、必要に応じて界面活性剤(カチオン
性、両性、又はノニオン性)やpH緩衝剤を含有させる
ことができる。Furthermore, the water-absorbing layer can contain a surfactant (cationic, amphoteric, or nonionic) and a pH buffer, if necessary.
吸水層には、吸水層が検出層を兼ねる場合、光遮蔽性(
反射性又は光吸収性)微粒子を必要に応じて含有させる
ことができる。When the water absorption layer also serves as a detection layer, the water absorption layer has light shielding properties (
Reflective or light-absorbing) fine particles may be included as necessary.
吸水層、光遮蔽層、V過層、試薬層等の層の上には、展
開層を接着し積層するための接着層を設けてもよい、接
着層は水で湿潤しているとき、又は水を含んで膨潤した
ときに展開層を接着することができるような親水性ポリ
マーからなることが好ましい、接着層に用いることがで
きる親水性ポリマーの例としては、吸水層に用いられる
と同様な親水性ポリマーがあげられる。これらのうちで
はゼラチン、ゼラチン誘導体、ポリアクリルアミド等が
好ましい、接着層の乾燥膜厚は一般に約0.5μlから
約20μ騎、好ましくは約1μmから約1071zの範
囲である。なお、接着層は試薬層と展開層の間の他に、
他の眉間の接着力を向上させるため所望の211!lの
間に設けてもよい、接着層は親水性ポリマーと、必要に
よって加えられる界面活性剤等を含む水溶液を公知の方
法で、試薬層等の上に塗布する方法などにより設けるこ
とができる。An adhesive layer may be provided on the water absorption layer, light shielding layer, V overlayer, reagent layer, etc. for adhering and laminating the spreading layer. When the adhesive layer is wet with water, or It is preferable to be made of a hydrophilic polymer that can bond the spreading layer when swollen with water. Examples include hydrophilic polymers. Among these, gelatin, gelatin derivatives, polyacrylamide, etc. are preferred, and the dry film thickness of the adhesive layer is generally in the range of about 0.5 μl to about 20 μl, preferably about 1 μm to about 1071 μm. In addition to the adhesive layer between the reagent layer and the developing layer,
Desired 211 to improve adhesion between other eyebrows! The adhesive layer that may be provided between the reagent layer and the like can be provided by applying an aqueous solution containing a hydrophilic polymer and a surfactant added as necessary on the reagent layer, etc., using a known method.
光遮蔽層は、親水性ポリマーをバインダーとして、光反
射性微粒子が分散されている水浸透性の層であることが
好ましい、光反射性微粒子は、試薬R(又は吸水N)に
生じた検出可能な変化(色変化、発色等)を光透過性を
有する支持体側から反射測光する際に、展開層に点着供
給された水性液体の色、特に試料が全血である場合のヘ
モグロビンの赤色等を遮蔽するとともに光反射層または
背景層としても機能する。光反射性を有する微粒子の例
としては、二酸化チタン微粒子、硫酸バリウム微粒子が
好ましい、必要に応じ展開層中にも上記のごとき光遮蔽
性微粒子を含有させてもよい。The light shielding layer is preferably a water-permeable layer in which light-reflecting fine particles are dispersed using a hydrophilic polymer as a binder.The light-reflecting fine particles are detectable particles generated in reagent R (or water absorption N) When measuring changes in color (color change, color development, etc.) from the light-transmitting support side, the color of the aqueous liquid dotted onto the developing layer, especially the red color of hemoglobin when the sample is whole blood, etc. It also functions as a light reflective layer or background layer. As examples of the light-reflecting fine particles, titanium dioxide fine particles and barium sulfate fine particles are preferable.If necessary, the above-mentioned light-shielding fine particles may be included in the developing layer.
多孔性液体展開層は、液体計量作用を有する展開層であ
ることが好ましい、液体計量作用を有するとは、その表
面に点着供給された液体試料を、その中に含有している
成分を実質的に偏在させることなく、横方向(層の平面
に沿う方向)に単位面積当りほぼ一定量の割合で広げ下
側の層に液体試料を供給する作用を有することである。It is preferable that the porous liquid spreading layer is a spreading layer that has a liquid metering function. Having a liquid metering function means that the porous liquid spreading layer can substantially absorb the components contained therein when the liquid sample is dotted onto its surface. It has the function of supplying the liquid sample to the lower layer by spreading it at a rate of a substantially constant amount per unit area in the lateral direction (direction along the plane of the layer) without causing it to be unevenly distributed.
展開層のマトリックスを構成する材料としては、1紙、
不織布、織物生地(例、ブロード、ボブリン等の平織等
)、編物生地(例、トリコット編、ダブルトリコット編
、ミラニーズ編等)、ガラス繊維P紙、メンブランフィ
ルタ−(プラッシュポリマー層)、あるいはポリマーミ
クロビーズ等からなる三次元格子状構造物等を用いるこ
とができる。これらのうちでは、織物生地および編物生
地に代表される繊維質層を用いることが好ましい、これ
らの詳細については特開昭55−164356号、特開
昭57−66359号及び特開昭60−222769号
を参照すればよい。The materials constituting the matrix of the development layer include 1 paper,
Non-woven fabrics, woven fabrics (e.g. plain weave such as broad, boblin, etc.), knitted fabrics (e.g. tricot knit, double tricot knit, Milanese knit, etc.), glass fiber P paper, membrane filter (plush polymer layer), or polymer micro A three-dimensional lattice structure made of beads or the like can be used. Among these, it is preferable to use fibrous layers represented by woven fabrics and knitted fabrics.For details, see JP-A-55-164356, JP-A-57-66359, and JP-A-60-222769. Please refer to the issue.
本発明の乾式分析要素に用いることができる織物布生地
又は編物布生地は水洗等の脱脂処理により少なくとも糸
、m物あるいは編物の製造時に付着した油脂類が実質的
に除去されていることが好ましい。The woven fabric or knitted fabric that can be used in the dry analysis element of the present invention is preferably subjected to degreasing treatment such as washing with water to substantially remove at least the oils and fats attached during the production of yarn, m-type fabric, or knitted fabric. .
展開層、発色試薬層、反応試薬層又は吸水層には液体試
料を適用して分析操作を実施する時の要素内のpHを約
4.5から約9.0の範囲内の適宜な値に維持しうる公
知のp H1118剤から適宜に選択して含有させるこ
とができる。用いうるvI街剤としては、日本化学全編
「化学便覧基礎編」(東京、丸首:+1.1966年発
行>1312〜1320頁、R,M、C,Dawson
eL al 編rDaLa for Bioches
ical Re5earct1」第2版(Oxford
at the C1arendon Press、19
69年発行)476〜508頁、’[1iocl+em
istry」第5巻467〜477頁(1966年)、
「^na−IyLical Bioche+*1str
y」第104巻300〜310頁(1980年)等に記
載のpHMfiI剤がある。When a liquid sample is applied to the developing layer, coloring reagent layer, reaction reagent layer, or water absorption layer and an analytical operation is performed, the pH within the element is adjusted to an appropriate value within the range of about 4.5 to about 9.0. The agent may be appropriately selected from known agents capable of maintaining pH 1118 and may be included. As a vI street agent that can be used, Nippon Kagaku complete edition "Chemistry Handbook Basic Edition" (Tokyo, Marukubi: +1. Published in 1966 > pages 1312-1320, R, M, C, Dawson
Edited by eL al DaLa for Bioches
ical Re5earct1” 2nd edition (Oxford)
at the C1arendon Press, 19
Published in 1969) pp. 476-508, '[1iocl+em
istry” Vol. 5, pp. 467-477 (1966),
“^na-IyLical Bioche+*1str
y, Vol. 104, pp. 300-310 (1980).
本発明の多層分析要素は前述の諸特許明細書に記載の公
知の方法により調製することができる。The multilayer analytical element of the present invention can be prepared by known methods as described in the aforementioned patent specifications.
本発明の多層分析要素は一辺約15mmから約30mm
の正方形またはほぼ同サイズの円形等の小片に裁断し、
特公昭57−28331.実開昭56−142454.
特開昭57−63452 、実開昭58−32350
、特表昭58−501144等に記載のスライド枠に収
めて化学分析スライドとして用いることが、製造、包装
、輸送、保存5測定操作等諸種の観点で好ましい、 (
−j!用目的によっては。The multilayer analytical element of the present invention has a side of about 15 mm to about 30 mm.
Cut into small pieces such as squares or circles of approximately the same size,
Special Publication No. 57-28331. Utsukai Showa 56-142454.
Japanese Patent Application Publication No. 57-63452, Utility Application Publication No. 58-32350
It is preferable to use it as a chemical analysis slide by placing it in the slide frame described in Japanese Patent Application Publication No. 58-501144, etc., from various viewpoints such as manufacturing, packaging, transportation, storage, and measurement operations. (
-j! Depending on the purpose.
長いテープ状でカセットまたはマガジンに収めて用いる
こと、または小片を開口のあるカードに貼付または収め
て用いることができる。It can be used in the form of a long tape stored in a cassette or magazine, or in small pieces attached or stored in a card with an opening.
本発明の多層分析要素は前述の諸特許明細書等に記載の
操作により液体試料中のアナライトであるコレステロー
ルの定量分析を実施できる。すなわち約5.Lから約3
0uL、好ましくは8uLから15LILの範囲の全血
、血漿、血清、尿等の水性液体試料滴を展開層に点着し
、1分から10分の範囲で、約20℃から約40°Cの
範囲の実質的に一定の温度で、好ましくは37℃近傍の
実質的に一定の温度でインクベーションし、要素内の発
色又は変色を可視光又は紫外光の吸収極大波長またはそ
の近傍の波長の光を用いて光透過性支持体側から反射測
光し、予め作成した検量線を用いて比色測定法の処理に
より液体試料中の総コレスプロール含有量を求めること
ができる。あるいは、要素内の蛍光の強度を測光し、予
め作成した検量線分用いて液体試料中の総コレステロー
ル含有量を求めることができる9点着する液体X料の量
、インクベーション時間及び温度を一定にすることによ
りアナライトの定量分析を高精度で実施できる。測定操
作は特開昭60−125543、特開昭60−2208
82、特開昭61−294367、特開昭58−161
867等に記載の化学分析装置により極めて容易な操作
で高精度の定量分析を実施できる。The multilayer analysis element of the present invention can perform quantitative analysis of cholesterol, which is an analyte, in a liquid sample by the operations described in the above-mentioned patent specifications. That is, about 5. Approximately 3 from L
A sample drop of an aqueous liquid such as whole blood, plasma, serum, urine, etc. in the range of 0 uL, preferably 8 uL to 15 LIL is placed on the spreading layer, and the sample is heated in the range of about 20°C to about 40°C for 1 to 10 minutes. Incubation is carried out at a substantially constant temperature, preferably around 37° C., to induce color development or discoloration within the element by exposing it to light at or near the maximum absorption wavelength of visible or ultraviolet light. The total cholesprol content in a liquid sample can be determined by performing reflection photometry from the light-transmitting support side using a colorimetric method using a previously prepared calibration curve. Alternatively, the total cholesterol content in the liquid sample can be determined by photometrically measuring the intensity of fluorescence within the element and using a calibration curve prepared in advance. By doing so, quantitative analysis of analytes can be performed with high precision. Measurement operation was performed using Japanese Patent Application Laid-open No. 60-125543 and Japanese Patent Laid-open No. 60-2208.
82, JP 61-294367, JP 58-161
The chemical analyzer described in 867 and the like allows highly accurate quantitative analysis to be performed with extremely easy operation.
[以下余白]
[実施例1]
ゼラチン下塗が設けられている厚さ180μ鏑のポリエ
チレンテレフタレート(PET)無色透明平滑フィルム
(支持体)の上に下記の組成の発色層形成用水溶液を乾
燥膜厚が15μ…になるよう塗布し、乾燥して発色層を
設けた。[Left below] [Example 1] A colorless transparent smooth polyethylene terephthalate (PET) film (support) having a thickness of 180 μm and provided with a gelatin undercoat is coated with an aqueous solution for forming a coloring layer having the following composition and dried to a film thickness of 180 μm. It was coated to a thickness of 15 μm and dried to form a coloring layer.
発色層形成用水溶液の成分
アルカリ処理ゼラチン 12 gノニルフェノキ
シポリグリシドール
(グリシドール単位平均10含有) 0.3gNAD
o、sgジアホラーゼ
28001ONTI3(*)
0.2g水
95m1* 3.3’−(3,3’−ジメトキ
シ−4,4′−ビフェニレン)ビス[2−(p−ニトロ
フェニル)−5−フェニル−2H−テトラゾリウム ク
ロリド]
次に発色層の上に、下記の組成の光遮蔽層形成用水溶液
を乾燥膜厚が7μ哨になるよう塗布し、乾燥して光遮蔽
層を設けた。Components of aqueous solution for forming coloring layer Alkali-treated gelatin 12 g Nonylphenoxy polyglycidol (contains an average of 10 glycidol units) 0.3 g NAD
o, sg diaphorase
28001ONTI3(*)
0.2g water
95ml* 3.3'-(3,3'-dimethoxy-4,4'-biphenylene)bis[2-(p-nitrophenyl)-5-phenyl-2H-tetrazolium chloride] Next, on the coloring layer, An aqueous solution for forming a light-shielding layer having the composition shown below was coated to give a dry film thickness of 7 μm, and was dried to form a light-shielding layer.
光遮蔽層形成用水溶液
アルカリ処理ゼラチン 14gルチル型酸化チ
タン 70ビ水100+會1
光遮蔽層の上に、下記の組成のゼラチン水溶液を乾燥膜
厚が2μmになるよう塗布し、乾燥して接着層を設けた
。Aqueous alkali-treated gelatin for forming a light shielding layer 14g Rutile titanium oxide 70 Bisui 100 + Kai 1 On the light shielding layer, apply an aqueous gelatin solution with the following composition to a dry film thickness of 2 μm, and dry to form an adhesive layer. has been established.
接着層形成用水溶液
アリカリ処理ゼラチン 4g
ノニルフエノキシボリエトキシエタノール(オキシエチ
レン単位平均10含有) 0.1゜水
90g接着層の上に約30H
7m2の割合で水を全面にほぼ一様に供給して湿潤させ
た後、グロー放電により親水化したPET紡績糸製トリ
コットtA物布生地(糸の太さ50デニール相当、布の
厚さ平均250μm)を軽く圧力をかけながらラミネー
トし、乾燥して接着させて布rA開層を設けた。Aqueous alkali-treated gelatin for adhesive layer formation 4g Nonylphenoxybolyethoxyethanol (contains 10 oxyethylene units on average) 0.1° water
Approximately 30H on top of 90g adhesive layer
Water was supplied almost uniformly to the entire surface at a rate of 7 m2 to moisten it, and then a tricot tA fabric made of PET spun yarn was made hydrophilic by glow discharge (thickness of the thread was equivalent to 50 denier, and the average thickness of the cloth was 250 μm). ) were laminated with light pressure, dried and adhered to form a fabric rA open layer.
布展開層の上に、下記組成のコレステロール分析用試i
組成物の水懸濁液を200m1/+n’の割合でほぼ均
一に塗布し、乾燥させてコレステロール定量用一体型多
層分析要素を調製した。Cholesterol analysis sample I having the following composition was placed on the cloth spreading layer.
An aqueous suspension of the composition was applied almost uniformly at a ratio of 200 ml/+n' and dried to prepare an integrated multilayer analytical element for cholesterol quantification.
エタノール 5001ポリビニルピ
ロリドン(平均分子i36万)(10%エタノール溶液
)18g
2−アミノ−2−エチル−1,3−プロパンジオール1
g
ノニルフェノキシポリエトキシエタノール(オキシエチ
レン単位平均40含有)fzrノニルフエノキシボリグ
リシドール
(グリシドール単位平均IO含有) 3gデオキシコ
ール酸ナトリウム 7g
上記エタノール溶液に下記酵素液を添加し、懸濁させた
。Ethanol 5001 polyvinylpyrrolidone (average molecule i 360,000) (10% ethanol solution) 18g 2-amino-2-ethyl-1,3-propanediol 1
g Nonylphenoxypolyethoxyethanol (contains 40 oxyethylene units on average) fzr nonylphenoxyboriglycidol (contains IO on average in glycidol units) 3 g Sodium deoxycholate 7 g The following enzyme solution was added to the above ethanol solution and suspended.
リパーゼ(* ) 15000 Ill
コレステロールデヒドロゲナーゼ
5000 Ill
水 51*
Chromobacteriu−νiscosumか
ら産生えられたコレステロール定量用一体型多層分析要
素を15mmX 15m5の正方形に裁断し、プラスチ
ック製マウントに収めて、コレステロール定量用分析ス
ライドを完成した。Lipase (*) 15000 Ill
Cholesterol Dehydrogenase 5000 Ill Water 51*
An integrated multilayer analytical element for cholesterol quantification produced from Chromobacterium viscosum was cut into squares of 15 mm x 15 m5 and placed in a plastic mount to complete an analytical slide for cholesterol quantification.
コレステロール濃度の異なる人血漿10μIを分 。Distribute 10 μl of human plasma with different cholesterol concentrations.
析スライドの展開層に点着し、37℃で6分インクベー
ションした後、中心波長600n−の可視光でPET支
持体側から反射光学濃度を測定した。その結果を第1表
に示す。It was spotted on the developing layer of an analysis slide, and after incubation at 37° C. for 6 minutes, the reflected optical density was measured from the PET support side using visible light with a center wavelength of 600 nm. The results are shown in Table 1.
第 1 表
[実施例2]
実施例1と同様のPETフィルムの上に下記組成の水溶
液で乾燥膜厚が15μ鋼になるように塗布、乾燥し発色
層を設けた。Table 1 [Example 2] On the same PET film as in Example 1, an aqueous solution having the following composition was coated so that the dry film thickness was 15μ steel, and dried to provide a coloring layer.
アルカリ処理ゼラチン 12 gノニルフェノキ
シポリグリシドール
(グリシドール単位平均10倉有) 0.1 。Alkali-treated gelatin 12 g nonylphenoxy polyglycidol (glycidol unit average 10 units) 0.1.
ジアホラーゼ 3000 UNTB
O,35゜ビス(ビニルスルホニ
ルメチルカルボニルアミノ)メタン
0.12 g水
105 g次に下記組成の水懸濁液で乾燥膜厚が7μ蹟
になるように塗布、乾燥して光遮蔽層を設けた。Diaphorase 3000 UNTB
O, 35゜bis(vinylsulfonylmethylcarbonylamino)methane
0.12 g water
105 g Next, an aqueous suspension having the following composition was coated to a dry film thickness of 7 μm, and dried to provide a light shielding layer.
アルカリ処理ゼラチン 7g
ルチル型酸化チタン 35 g水
501次にコレステロー
ルデヒドロゲナーゼを含む接着層を下記処方で乾燥膜厚
4μ鍋になるように塗布、乾燥して設けた。Alkali-treated gelatin 7g Rutile titanium oxide 35g Water
501 Next, an adhesive layer containing cholesterol dehydrogenase was applied using the following formulation to a dry film thickness of 4 μm and dried.
コレステロールデヒドロゲナーゼ
39000 U
NAD 0.9gアルカリ処理
ゼラチン 20 。Cholesterol dehydrogenase 39000 U NAD 0.9g Alkaline processed gelatin 20.
ノニルフェノキシポリグリシドール
(グリシドール単位平均10含有)0.2 g水
220 g接着層の上に
30g/m2の割合で湿し水を供給湿潤させた後、実施
例1と同様のPETvJ績糸製編物布生地を軽く圧着し
つつラミネート接着して布展開層を設けた。Nonylphenoxy polyglycidol (contains an average of 10 glycidol units) 0.2 g water
After dampening the 220 g adhesive layer by supplying dampening water at a rate of 30 g/m2, the same PETvJ yarn knitted fabric as in Example 1 was laminated and adhered while being lightly pressed to form a cloth spreading layer. Ta.
次にこの布展開層の上に、下記組成のコレステロール分
析用試薬組成物の水懸濁液を20On+I/m2の割合
でほぼ均一に塗布し、乾燥させてコレステロール定量用
一体型多層分析要素を調製した。Next, on this cloth spread layer, an aqueous suspension of a reagent composition for cholesterol analysis having the following composition is almost uniformly applied at a rate of 20 On + I/m2, and dried to prepare an integrated multilayer analytical element for cholesterol quantification. did.
エタノール 500閘1ポリビニル
ピロリドン(平均分子量36万)(10%エタノール溶
液)18g
2−アミノ−2−メチル−1,3−プロパンジオール1
g
デオキシコール酸ナトリウム 7g
ノニルフエノキシボリエトキシエタノール(オキシエチ
レン単位平均40含有)6 gノニルフェノキシポリグ
リシドール
(グリシドール単位平均10含有) 3g上記エタノ
ール溶液に下記酵素液を添加した。Ethanol 500 increments 1 polyvinylpyrrolidone (average molecular weight 360,000) (10% ethanol solution) 18 g 2-amino-2-methyl-1,3-propanediol 1
g Sodium deoxycholate 7 g Nonylphenoxybolyethoxyethanol (contains an average of 40 oxyethylene units) 6 g Nonylphenoxy polyglycidol (contains an average of 10 glycidol units) 3 g The following enzyme solution was added to the above ethanol solution.
リパーゼC* > 15000 [1水
3g*
Chromobacterium viscosu+*
から産生えられた要素を実施例1と同様にしてコレステ
ロール定型用化学分析スライドを完成した0次に実施例
1と同様の方法で検量線を作成した結果第2表の値を得
た。Lipase C* > 15000 [1 water 3g*
Chromobacterium viscosu+*
A chemical analysis slide for cholesterol standardization was completed using the elements produced in the same manner as in Example 1. Next, a calibration curve was prepared in the same manner as in Example 1, and the values shown in Table 2 were obtained.
第 2 表
[実施例3]
リパーゼ1500010のかわりにコレステロールエス
テラーゼ120001Uを用いたほかは実施例2と同様
にして、実施例2と同様の結果がえられた。Table 2 [Example 3] The same results as in Example 2 were obtained in the same manner as in Example 2 except that cholesterol esterase 120001U was used instead of lipase 1500010.
Claims (1)
接触しうる状態で有する乾式分析要素であつて、前記展
開層にコレステロールエステル加水分解活性を有する酵
素を含み、前記展開層又は前記の少なくとも一つの水透
過性層にアルキルフェノキシポリグリシドールを含む乾
式分析要素。A dry analytical element having at least one water-permeable layer and a porous liquid spreading layer in a state where they can come into liquid contact with each other, wherein the spreading layer contains an enzyme having cholesterol ester hydrolysis activity; Dry analytical element containing alkyl phenoxy polyglycidol in one water permeable layer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP11503586 | 1986-05-20 | ||
JP61-115035 | 1986-05-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63109799A true JPS63109799A (en) | 1988-05-14 |
JPH0671440B2 JPH0671440B2 (en) | 1994-09-14 |
Family
ID=14652592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP11763687A Expired - Lifetime JPH0671440B2 (en) | 1986-05-20 | 1987-05-14 | Dry cholesterol analytical element |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0671440B2 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6071392A (en) * | 1997-06-03 | 2000-06-06 | Matsushita Electric Industrial Co., Ltd. | Cholesterol sensor |
US6117289A (en) * | 1996-12-20 | 2000-09-12 | Matsushita Electric Industrial Co., Ltd. | Cholesterol sensor and method for producing the same |
EP2233578A1 (en) | 2009-03-25 | 2010-09-29 | Fujifilm Corporation | Method for measuring low density lipoprotein cholesterol |
-
1987
- 1987-05-14 JP JP11763687A patent/JPH0671440B2/en not_active Expired - Lifetime
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6117289A (en) * | 1996-12-20 | 2000-09-12 | Matsushita Electric Industrial Co., Ltd. | Cholesterol sensor and method for producing the same |
US6071392A (en) * | 1997-06-03 | 2000-06-06 | Matsushita Electric Industrial Co., Ltd. | Cholesterol sensor |
EP2233578A1 (en) | 2009-03-25 | 2010-09-29 | Fujifilm Corporation | Method for measuring low density lipoprotein cholesterol |
US8357502B2 (en) | 2009-03-25 | 2013-01-22 | Fujifilm Corporation | Method for measuring low density lipoprotein cholesterol |
Also Published As
Publication number | Publication date |
---|---|
JPH0671440B2 (en) | 1994-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4452887A (en) | Integral multi-layered element containing glucose oxidase for determining glucose | |
EP0254117B1 (en) | Immunoassay process | |
US4587100A (en) | Multilayer analytical element for the detection of hydrogen peroxide | |
US5004685A (en) | Dry-type multilayer analytical element | |
EP1037048A2 (en) | Quantitative analysis of glucose or cholesterol in whole blood | |
US6255061B1 (en) | Analytical element for the analysis of whole blood | |
JPH0721455B2 (en) | Tools and Methods for Analyzing Specific Components in Liquid Samples | |
US5063153A (en) | Integral multilayer analytical element | |
US4897347A (en) | Multilayer analysis film for analyzing transaminase | |
US5215716A (en) | Integral multilayer analytical element | |
EP0244825A1 (en) | Dry-type analytical element for cholesterol | |
JPS63109799A (en) | Dry cholesterol-analyzing element | |
JPH02208565A (en) | Method and device for separating plasma from blood and analyzing element used for said method | |
JP3167508B2 (en) | Inorganic phosphorus determination reagent and dry analytical element | |
JP4003993B2 (en) | Method for producing dry analytical element and dry analytical element | |
JPS6394994A (en) | Dry analytical element containing oxidized form coenzyme and production thereof | |
USH600H (en) | Whole blood analytical element and method of analyzing whole blood using the same | |
US5506116A (en) | Method and element for assay of catechol and catechol generating substances | |
JP2006087325A (en) | Analytical reagent, dry analytical element and analytical method | |
JP3639392B2 (en) | Dry measurement test equipment | |
JPH0522520B2 (en) | ||
JP2000258414A (en) | Integrally formed multilayer chemical analysis element and quantitative method | |
JPH03262967A (en) | Method for determining high specific gravity lipoprotein cholesterol | |
JPS63119697A (en) | Element for analysis of cholesterol | |
JPH0578314B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20070914 Year of fee payment: 13 |